# Anlotinib Single Drug as the Maintenance Treatment for Advanced NSCLC

> **NCT03998085** · NA · UNKNOWN · sponsor: **The First Hospital of Jilin University** · enrollment: 40 (estimated)

## Conditions studied

- Non-Small Cell Lung Cancer

## Interventions

- **DRUG:** Anlotinib Hydrochloride

## Key facts

- **NCT ID:** NCT03998085
- **Lead sponsor:** The First Hospital of Jilin University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-03-05
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03998085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03998085, "Anlotinib Single Drug as the Maintenance Treatment for Advanced NSCLC". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03998085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*